ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04080	Neuroactive ligand-receptor interaction	81/360	423/7206	9.08105325385e-28
ko05033	Nicotine addiction	25/360	56/7206	1.74034068079e-18
ko04024	cAMP signaling pathway	41/360	279/7206	2.59500719391e-10
ko04724	Glutamatergic synapse	29/360	152/7206	2.62978926526e-10
ko04728	Dopaminergic synapse	32/360	185/7206	4.24643404956e-10
ko04727	GABAergic synapse	24/360	110/7206	5.58125584649e-10
ko05032	Morphine addiction	24/360	110/7206	5.58125584649e-10
ko04723	Retrograde endocannabinoid signaling	28/360	175/7206	3.26306107725e-08
ko04721	Synaptic vesicle cycle	18/360	80/7206	5.07717430397e-08
ko05030	Cocaine addiction	17/360	73/7206	6.99580791623e-08
ko04713	Circadian entrainment	22/360	136/7206	8.36743780635e-07
ko04742	Taste transduction	13/360	61/7206	7.18544706899e-06
ko05014	Amyotrophic lateral sclerosis (ALS)	14/360	74/7206	1.3819626756e-05
ko04261	Adrenergic signaling in cardiomyocytes	25/360	205/7206	2.82517447169e-05
ko00604	Glycosphingolipid biosynthesis - ganglio series	6/360	14/7206	3.182445319e-05
ko04725	Cholinergic synapse	21/360	160/7206	4.19803997338e-05
ko04726	Serotonergic synapse	19/360	137/7206	4.53197658554e-05
ko04010	MAPK signaling pathway	33/360	321/7206	6.31101613565e-05
ko05203	Viral carcinogenesis	2/360	277/7206	0.00011287388615
ko04921	Oxytocin signaling pathway	23/360	209/7206	0.000301763177245
ko05169	Epstein-Barr virus infection	1/360	206/7206	0.000498817564886
ko05031	Amphetamine addiction	13/360	91/7206	0.000538263185565
ko04060	Cytokine-cytokine receptor interaction	1/360	191/7206	0.00107906829582
ko04260	Cardiac muscle contraction	13/360	98/7206	0.00109994907612
ko05412	Arrhythmogenic right ventricular cardiomyopathy (ARVC)	11/360	79/7206	0.00175967866081
ko04911	Insulin secretion	14/360	117/7206	0.00197792168081
ko04020	Calcium signaling pathway	25/360	265/7206	0.00215352799221
ko03013	RNA transport	1/360	166/7206	0.00333166491522
ko05164	Influenza A	1/360	167/7206	0.0033557918952
ko05414	Dilated cardiomyopathy	13/360	112/7206	0.00370403358689
ko00533	Glycosaminoglycan biosynthesis - keratan sulfate	4/360	15/7206	0.00538935057052
ko00603	Glycosphingolipid biosynthesis - globo and isoglobo series	3/360	8/7206	0.00573755083591
ko05152	Tuberculosis	2/360	187/7206	0.00616509900102
ko05322	Systemic lupus erythematosus	1/360	151/7206	0.00709730459382
ko04932	Non-alcoholic fatty liver disease (NAFLD)	2/360	182/7206	0.00880324752863
ko04510	Focal adhesion	4/360	240/7206	0.0101503131826
ko05205	Proteoglycans in cancer	5/360	271/7206	0.0101716277472
ko03040	Spliceosome	1/360	145/7206	0.0105210098909
ko05410	Hypertrophic cardiomyopathy (HCM)	11/360	100/7206	0.0165909184102
ko04140	Autophagy - animal	2/360	164/7206	0.0174957740792
ko04068	FoxO signaling pathway	2/360	167/7206	0.0177530509936
ko01200	Carbon metabolism	1/360	128/7206	0.0217541638436
ko04970	Salivary secretion	10/360	95/7206	0.0271157621434
ko04912	GnRH signaling pathway	1/360	122/7206	0.0321666451918
ko05168	Herpes simplex infection	3/360	182/7206	0.0362278725442
ko04141	Protein processing in endoplasmic reticulum	3/360	184/7206	0.0368997420466
ko00250	Alanine, aspartate and glutamate metabolism	5/360	38/7206	0.039175698531
ko05200	Pathways in cancer	15/360	492/7206	0.0409840921498
ko00240	Pyrimidine metabolism	1/360	110/7206	0.0444760452227
ko05215	Prostate cancer	1/360	111/7206	0.0447729443501
ko04120	Ubiquitin mediated proteolysis	2/360	138/7206	0.0482412126669
ko05161	Hepatitis B	3/360	173/7206	0.0493515255835
ko02025	Biofilm formation - Pseudomonas aeruginosa	1/360	1/7206	0.0499583680268